Wierzbicka-Rucińska, A.; Kubiszewska, I.; Grzywa-Czuba, R.; Gackowska, L.; Szalecki, M.; Michałkiewicz, J.; Trojanek, J.B.
Implications of the Matrix Metalloproteinases, Their Tissue Inhibitors and Some Other Inflammatory Mediators Expression Levels in Children Obesity-Related Phenotypes. J. Pers. Med. 2024, 14, 317.
https://doi.org/10.3390/jpm14030317
AMA Style
Wierzbicka-Rucińska A, Kubiszewska I, Grzywa-Czuba R, Gackowska L, Szalecki M, Michałkiewicz J, Trojanek JB.
Implications of the Matrix Metalloproteinases, Their Tissue Inhibitors and Some Other Inflammatory Mediators Expression Levels in Children Obesity-Related Phenotypes. Journal of Personalized Medicine. 2024; 14(3):317.
https://doi.org/10.3390/jpm14030317
Chicago/Turabian Style
Wierzbicka-Rucińska, Aldona, Izabela Kubiszewska, Renata Grzywa-Czuba, Lidia Gackowska, Mieczysław Szalecki, Jacek Michałkiewicz, and Joanna Beata Trojanek.
2024. "Implications of the Matrix Metalloproteinases, Their Tissue Inhibitors and Some Other Inflammatory Mediators Expression Levels in Children Obesity-Related Phenotypes" Journal of Personalized Medicine 14, no. 3: 317.
https://doi.org/10.3390/jpm14030317
APA Style
Wierzbicka-Rucińska, A., Kubiszewska, I., Grzywa-Czuba, R., Gackowska, L., Szalecki, M., Michałkiewicz, J., & Trojanek, J. B.
(2024). Implications of the Matrix Metalloproteinases, Their Tissue Inhibitors and Some Other Inflammatory Mediators Expression Levels in Children Obesity-Related Phenotypes. Journal of Personalized Medicine, 14(3), 317.
https://doi.org/10.3390/jpm14030317
